Revenio Group Oyj (HEL:REG1V)

Market Cap	633.00M
Revenue (ttm)	103.82M
Net Income (ttm)	18.50M
Shares Out	26.60M
EPS (ttm)	0.70
PE Ratio	34.24
Forward PE	26.92
Dividend	0.40 (1.75%)
Ex-Dividend Date	Apr 11, 2025

Volume	37,332
Average Volume	21,057
Open	23.90
Previous Close	23.80
Day's Range	23.40 - 23.90
52-Week Range	21.35 - 35.84
Beta	1.48
RSI	46.11
Earnings Date	Apr 29, 2025

About Revenio Group Oyj

Revenio Group Oyj, provides ophthalmological devices and software solutions for the diagnosis of glaucoma, macular degeneration, and diabetic retinopathy in the United States, Finland, and internationally. The company offers intraocular pressure measuring devices, retinal imaging equipment, perimeters, as well as software solutions under the iCare brand. Its product portfolio includes iCare IC100, IC200, ST500, TONOVET Pro, and TONOVET Plus tonometers; iCare HOME2, a home intraocular pressure monitor; and iCare Sensors, an accessories for iCare...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2001
• Employees: 241
• Stock Exchange: Nasdaq Helsinki
• Ticker Symbol: REG1V

Financial Performance

In 2024, Revenio Group Oyj's revenue was 103.82 million, an increase of 7.27% compared to the previous year's 96.79 million. Earnings were 18.50 million, a decrease of -3.20%.